Home Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
 

Keywords :   


Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting

2014-07-02 10:27:34| drugdiscoveryonline Home Page

Euroscreen, a private drug development company, announced today that its ESN364 Phase I clinical candidate, will be presented at the ICE/ENDO Meeting on Sunday, June 22nd (Chicago, IL)

Tags: the health present meeting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »